Healio (5/13, Ernst) reports researchers found “entorhinal hypometabolism identified on fluorodeoxyglucose PET scans served as a ‘strong and independent predictor’ of future cognitive decline in” patients with preclinical Alzheimer’s disease. The findings were published in Neurology.
Related Links:
— “Entorhinal hypometabolism on PET scan predicts cognitive decline in preclinical AD “Julia Ernst, Healio, May 13, 2021